Home Cart Sign in  
Chemical Structure| 182167-02-8 Chemical Structure| 182167-02-8

Structure of Acolbifene
CAS No.: 182167-02-8

Chemical Structure| 182167-02-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Acolbifene (EM652) is a fourth-generation selective estrogen receptor antagonist with a LC50 value of 22±3 nM.

Synonyms: EM-652; SCH 57068

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Acolbifene

CAS No. :182167-02-8
Formula : C29H31NO4
M.W : 457.56
SMILES Code : OC1=CC=C2C(C)=C(C3=CC=C(O)C=C3)[C@H](C4=CC=C(OCCN5CCCCC5)C=C4)OC2=C1
Synonyms :
EM-652; SCH 57068
MDL No. :MFCD09837712

Safety of Acolbifene

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01452373 Vasomotor Symptoms ... More >> Hot Flushes Less << Phase 3 Completed - Canada, New Brunswick ... More >> EndoCeutics site # 06 Bathurst, New Brunswick, Canada, E2A 4X7 Canada, Ontario EndoCeutics site # 70 Burlington, Ontario, Canada, L7M 4Y1 EndoCeutics site # 69 Corunna, Ontario, Canada, N0N 1G0 EndoCeutics site # 73 Kitchener, Ontario, Canada, N2G 1H6 EndoCeutics site # 71 London, Ontario, Canada, N5Y 5K7 EndoCeutics site # 72 Newmarket, Ontario, Canada, L3Y 5G8 EndoCeutics site # 68 Sarnia, Ontario, Canada, N7T 4X3 Canada, Quebec EndoCeutics site # 04 Drummondville, Quebec, Canada, J2B 7T1 EndoCeutics site # 12 Montreal, Quebec, Canada, H4N 3C5 EndoCeutics site # 02 Quebec City, Quebec, Canada, G1S 2L6 EndoCeutics site # 01 Quebec City, Quebec, Canada, G1V 2L9 EndoCeutics site # 08 Shawinigan, Quebec, Canada, G9N 2H6 EndoCeutics site # 11 Sherbrooke, Quebec, Canada, J1H 1Z1 EndoCeutics site # 18 St-Romuald, Quebec, Canada, G6W 5M6 EndoCeutics site # 67 Victoriaville, Quebec, Canada, G6P 6P6 Less <<
NCT00853996 - Completed - -
NCT00853996 Breast Cancer Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.19mL

0.44mL

0.22mL

10.93mL

2.19mL

1.09mL

21.86mL

4.37mL

2.19mL

 

Historical Records

Categories